Evidence-based medicine and rare diseases

Area of Science:

• Medical Research Methodology
• Clinical Evidence Evaluation
• Patient Decision-Making

Background:

• Evidence-based medicine (EBM) principles are essential for clinical practice.
• High failure rates in drug development underscore the need for robust evidence.
• Unlicensed treatments, though well-intentioned, pose risks due to limited testing.

Purpose of the Study:

• To clarify the scope and limitations of evidence-based medicine.
• To explore diverse sources of reliable clinical evidence beyond randomized controlled trials.
• To address challenges in patient decision-making regarding medical treatments.

Main Methods:

• Discussion of the definition and application of evidence-based medicine.
• Analysis of drug development failure rates and risks of untested treatments.
• Exploration of alternative evidence sources, including meta-analyses for rare diseases.

Main Results:

• Reliable evidence can originate from sources other than clinical trials.
• Meta-analyses offer solutions for evidence generation in rare diseases.
• Patients often struggle with informed decision-making due to poor risk understanding.

Conclusions:

• Evidence-based medicine requires critical appraisal of various evidence types.
• Randomized controlled trials are valuable but not the sole determinant of evidence quality.
• Guiding patients through evidence is vital for informed and sound medical choices.